Rankings
▼
Calendar
CRON
Cronos Group Inc.
$981M
FY 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$47M
Gross Profit
-$26M
-55.3% margin
Operating Income
-$219M
-469.6% margin
Net Income
-$73M
-156.5% margin
EPS (Diluted)
$-0.21
Cash Flow
Operating Cash Flow
-$145M
Free Cash Flow
-$180M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$218M
Stockholders' Equity
$1.7B
Cash & Equivalents
$1.1B
← Q1 2020
All Quarters
CRON FY 2020 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena